nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Cisplatin—peripheral nervous system neoplasm	0.36	0.561	CbGbCtD
Cefdinir—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.281	0.439	CbGbCtD
Cefdinir—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000486	0.00135	CcSEcCtD
Cefdinir—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000486	0.00135	CcSEcCtD
Cefdinir—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000486	0.00135	CcSEcCtD
Cefdinir—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000486	0.00135	CcSEcCtD
Cefdinir—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000486	0.00135	CcSEcCtD
Cefdinir—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000484	0.00135	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.00134	CcSEcCtD
Cefdinir—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00048	0.00134	CcSEcCtD
Cefdinir—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000479	0.00133	CcSEcCtD
Cefdinir—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000477	0.00133	CcSEcCtD
Cefdinir—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000476	0.00132	CcSEcCtD
Cefdinir—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000475	0.00132	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000475	0.00132	CcSEcCtD
Cefdinir—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000466	0.0013	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000462	0.00129	CcSEcCtD
Cefdinir—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.00128	CcSEcCtD
Cefdinir—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000457	0.00127	CcSEcCtD
Cefdinir—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.00127	CcSEcCtD
Cefdinir—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000453	0.00126	CcSEcCtD
Cefdinir—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000453	0.00126	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.00045	0.00125	CcSEcCtD
Cefdinir—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000449	0.00125	CcSEcCtD
Cefdinir—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000447	0.00125	CcSEcCtD
Cefdinir—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000445	0.00124	CcSEcCtD
Cefdinir—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.00124	CcSEcCtD
Cefdinir—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000441	0.00123	CcSEcCtD
Cefdinir—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000441	0.00123	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00122	CcSEcCtD
Cefdinir—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00044	0.00122	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.00122	CcSEcCtD
Cefdinir—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000439	0.00122	CcSEcCtD
Cefdinir—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000437	0.00122	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00121	CcSEcCtD
Cefdinir—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000436	0.00121	CcSEcCtD
Cefdinir—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000436	0.00121	CcSEcCtD
Cefdinir—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000435	0.00121	CcSEcCtD
Cefdinir—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000435	0.00121	CcSEcCtD
Cefdinir—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000431	0.0012	CcSEcCtD
Cefdinir—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00043	0.0012	CcSEcCtD
Cefdinir—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000428	0.00119	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.00119	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000425	0.00118	CcSEcCtD
Cefdinir—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000424	0.00118	CcSEcCtD
Cefdinir—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000422	0.00117	CcSEcCtD
Cefdinir—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000422	0.00117	CcSEcCtD
Cefdinir—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000421	0.00117	CcSEcCtD
Cefdinir—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000421	0.00117	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.00116	CcSEcCtD
Cefdinir—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000416	0.00116	CcSEcCtD
Cefdinir—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00115	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000411	0.00114	CcSEcCtD
Cefdinir—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.00114	CcSEcCtD
Cefdinir—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00041	0.00114	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.00113	CcSEcCtD
Cefdinir—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000407	0.00113	CcSEcCtD
Cefdinir—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000407	0.00113	CcSEcCtD
Cefdinir—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000406	0.00113	CcSEcCtD
Cefdinir—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00113	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.00112	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.00112	CcSEcCtD
Cefdinir—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000399	0.00111	CcSEcCtD
Cefdinir—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.00111	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00111	CcSEcCtD
Cefdinir—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000398	0.00111	CcSEcCtD
Cefdinir—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000398	0.00111	CcSEcCtD
Cefdinir—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000397	0.00111	CcSEcCtD
Cefdinir—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000394	0.0011	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.0011	CcSEcCtD
Cefdinir—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000392	0.00109	CcSEcCtD
Cefdinir—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000391	0.00109	CcSEcCtD
Cefdinir—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000391	0.00109	CcSEcCtD
Cefdinir—Rash—Topotecan—peripheral nervous system neoplasm	0.000391	0.00109	CcSEcCtD
Cefdinir—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000391	0.00109	CcSEcCtD
Cefdinir—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000391	0.00109	CcSEcCtD
Cefdinir—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000389	0.00108	CcSEcCtD
Cefdinir—Headache—Topotecan—peripheral nervous system neoplasm	0.000389	0.00108	CcSEcCtD
Cefdinir—Rash—Tretinoin—peripheral nervous system neoplasm	0.000388	0.00108	CcSEcCtD
Cefdinir—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000388	0.00108	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000388	0.00108	CcSEcCtD
Cefdinir—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000388	0.00108	CcSEcCtD
Cefdinir—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000388	0.00108	CcSEcCtD
Cefdinir—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000386	0.00108	CcSEcCtD
Cefdinir—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000386	0.00107	CcSEcCtD
Cefdinir—Headache—Tretinoin—peripheral nervous system neoplasm	0.000385	0.00107	CcSEcCtD
Cefdinir—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000385	0.00107	CcSEcCtD
Cefdinir—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000385	0.00107	CcSEcCtD
Cefdinir—Constipation—Vincristine—peripheral nervous system neoplasm	0.000384	0.00107	CcSEcCtD
Cefdinir—Rash—Melphalan—peripheral nervous system neoplasm	0.000383	0.00107	CcSEcCtD
Cefdinir—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000383	0.00106	CcSEcCtD
Cefdinir—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00106	CcSEcCtD
Cefdinir—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00038	0.00106	CcSEcCtD
Cefdinir—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000379	0.00105	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000374	0.00104	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000374	0.00104	CcSEcCtD
Cefdinir—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000371	0.00103	CcSEcCtD
Cefdinir—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000369	0.00103	CcSEcCtD
Cefdinir—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000369	0.00103	CcSEcCtD
Cefdinir—Nausea—Topotecan—peripheral nervous system neoplasm	0.000368	0.00103	CcSEcCtD
Cefdinir—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000367	0.00102	CcSEcCtD
Cefdinir—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000366	0.00102	CcSEcCtD
Cefdinir—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000366	0.00102	CcSEcCtD
Cefdinir—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000364	0.00101	CcSEcCtD
Cefdinir—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000361	0.001	CcSEcCtD
Cefdinir—Nausea—Melphalan—peripheral nervous system neoplasm	0.000361	0.001	CcSEcCtD
Cefdinir—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000999	CcSEcCtD
Cefdinir—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000356	0.000992	CcSEcCtD
Cefdinir—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000355	0.000989	CcSEcCtD
Cefdinir—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000355	0.000989	CcSEcCtD
Cefdinir—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000347	0.000966	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000963	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000963	CcSEcCtD
Cefdinir—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000345	0.000961	CcSEcCtD
Cefdinir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000344	0.000958	CcSEcCtD
Cefdinir—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000344	0.000956	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000343	0.000955	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000948	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000934	CcSEcCtD
Cefdinir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000335	0.000931	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000924	CcSEcCtD
Cefdinir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000331	0.000922	CcSEcCtD
Cefdinir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.000918	CcSEcCtD
Cefdinir—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000324	0.000901	CcSEcCtD
Cefdinir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000322	0.000897	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000896	CcSEcCtD
Cefdinir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00032	0.00089	CcSEcCtD
Cefdinir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.000888	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000883	CcSEcCtD
Cefdinir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.000883	CcSEcCtD
Cefdinir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000316	0.000881	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000878	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000875	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000314	0.000875	CcSEcCtD
Cefdinir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000314	0.000874	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000868	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000868	CcSEcCtD
Cefdinir—Constipation—Etoposide—peripheral nervous system neoplasm	0.000311	0.000866	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000866	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000864	CcSEcCtD
Cefdinir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.000858	CcSEcCtD
Cefdinir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000307	0.000856	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000849	CcSEcCtD
Cefdinir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000299	0.000832	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000831	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000829	CcSEcCtD
Cefdinir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000298	0.000829	CcSEcCtD
Cefdinir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000297	0.000827	CcSEcCtD
Cefdinir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000297	0.000825	CcSEcCtD
Cefdinir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000818	CcSEcCtD
Cefdinir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000818	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000817	CcSEcCtD
Cefdinir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000293	0.000815	CcSEcCtD
Cefdinir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.000813	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.00081	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000803	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000803	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000803	CcSEcCtD
Cefdinir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000288	0.000801	CcSEcCtD
Cefdinir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000288	0.000801	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000801	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000799	CcSEcCtD
Cefdinir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000286	0.000795	CcSEcCtD
Cefdinir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000285	0.000794	CcSEcCtD
Cefdinir—Rash—Vincristine—peripheral nervous system neoplasm	0.000283	0.000789	CcSEcCtD
Cefdinir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000283	0.000788	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000786	CcSEcCtD
Cefdinir—Headache—Vincristine—peripheral nervous system neoplasm	0.000282	0.000784	CcSEcCtD
Cefdinir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.000771	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000769	CcSEcCtD
Cefdinir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000272	0.000757	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000756	CcSEcCtD
Cefdinir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000268	0.000746	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000743	CcSEcCtD
Cefdinir—Nausea—Vincristine—peripheral nervous system neoplasm	0.000267	0.000743	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00074	CcSEcCtD
Cefdinir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000261	0.000727	CcSEcCtD
Cefdinir—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000258	0.000717	CcSEcCtD
Cefdinir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000253	0.000703	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000699	CcSEcCtD
Cefdinir—Rash—Cisplatin—peripheral nervous system neoplasm	0.000251	0.000697	CcSEcCtD
Cefdinir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000697	CcSEcCtD
Cefdinir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000249	0.000693	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000686	CcSEcCtD
Cefdinir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000241	0.00067	CcSEcCtD
Cefdinir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000236	0.000657	CcSEcCtD
Cefdinir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000231	0.000644	CcSEcCtD
Cefdinir—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00023	0.00064	CcSEcCtD
Cefdinir—Rash—Etoposide—peripheral nervous system neoplasm	0.00023	0.000639	CcSEcCtD
Cefdinir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000229	0.000638	CcSEcCtD
Cefdinir—Headache—Etoposide—peripheral nervous system neoplasm	0.000228	0.000635	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000634	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000623	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000612	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000603	CcSEcCtD
Cefdinir—Nausea—Etoposide—peripheral nervous system neoplasm	0.000216	0.000602	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000601	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000592	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000592	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000579	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000576	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000568	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000566	CcSEcCtD
Cefdinir—Shock—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000559	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000558	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000556	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000556	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000548	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000541	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000536	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000526	CcSEcCtD
Cefdinir—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000517	CcSEcCtD
Cefdinir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000515	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000514	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000505	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000501	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.0005	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000494	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00049	CcSEcCtD
Cefdinir—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000486	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000475	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000467	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000464	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000463	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000457	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000454	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000449	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000449	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000449	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00043	CcSEcCtD
Cefdinir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000418	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000415	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000415	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000407	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000402	CcSEcCtD
Cefdinir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000389	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000387	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000377	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000376	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000372	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000361	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00036	CcSEcCtD
Cefdinir—Rash—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000358	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000358	CcSEcCtD
Cefdinir—Headache—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000356	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000348	CcSEcCtD
Cefdinir—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000337	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000334	CcSEcCtD
Cefdinir—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000331	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000331	CcSEcCtD
Cefdinir—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000329	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000312	CcSEcCtD
